Business Numinus ends fiscal year with revenue up 72% to $1.5M, losses of $19M The psychedelics firm has been aggressively expanding lab space while pushing ahead with clinical trials Natalia Buendia CalvilloDecember 10, 2021
Business Field Trip Health opens clinic in Vancouver: Q&A with founder Ronan Levy The new facility will feature the firm's ketamine-assisted therapy program, as well as a range of health and lifestyle services Nick LabaDecember 8, 2021
Medical and Pharmaceutical Psilocybin treats depression as well as common antidepressant: study The first head-to-head clinical trial pushes the psychedelic compound closer to becoming a licensed medicine Jared GnamApril 15, 2021
Medical and Pharmaceutical Nature amplifies therapeutic effects of psychedelics: study A recent review suggests natural settings and activities can complement all stages of psychedelic-assisted therapy Natalia Buendia CalvilloFebruary 23, 2021
Industry update Mydecine to make first legal import of psilocybin mushrooms into Canada Canada continues to open the door for clinical research the effectiveness of psilocybin for mental health treatments Jared GnamDecember 11, 2020
Psychedelics Psilocybin therapy 4 times more effective than antidepressants: study A first-of-its-kind clinical trial shows a dramatic drop in depression in over half of patients who received a synthetic version of the compound Jared GnamNovember 6, 2020
The weed wire Numinus Wellness kicks off inaugural psilocybin mushroom crop Psychedelic mushrooms will be grown for research purposes Michelle GamageSeptember 25, 2020
The weed wire UC Berkeley’s new psychedelic research centre wants to change your mind The new hub will focus on the rapidly advancing field by adding unique public education and spiritual components Jared GnamSeptember 16, 2020
The weed wire Mushroom company Mydecine acquires veteran-focused psychedelic firm With deep Canadian and U.S. military ties, NeuroPharm Inc. is about to launch psychedelic-based clinical trials Jared GnamJuly 15, 2020
Psychedelics Numinus licensed by Health Canada to extract and research psilocybin Extracting psilocybin from magic mushrooms will be cheaper than current method of creating synthetic compound for research, says company Michelle GamageJune 12, 2020